GLP-1 Drugs Linked to Lower Risk of Metastasis in Four Cancer Types (medpagetoday.com)

• GLP-1 drugs associated with lower metastasis risk
• Study focused on four tumor types
• Potential additional benefit beyond diabetes and obesity

"A new study finds that GLP-1 receptor agonists (such as Ozempic and Wegovy) are associated with a lower risk of cancer spread in four tumor types. The findings suggest an additional benefit of these drugs, which are primarily used for diabetes and obesity treatment."